ReviewInvestigative ophthalmology & visual science2026
Human Crystallin Variation and Cataract.
Review in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cataract is a leading cause of reversible childhood blindness worldwide and is largely attributable to mutations in crystallin-encoding genes of the α-, β-, and γ-crystallin families. Crystallins account for over 90% of total lens proteins and are indispensable for maintaining lens transparency and long-term proteostasis. These three crystallin families display distinct structural organizations and functional specializations: α-crystallins function as small heat shock proteins (sHSPs) with molecular chaperone activity, whereas β- and γ-crystallins serve primarily structural roles, characterized by conserved Greek-key motifs that support dense protein packing and appropriate refractive properties of the lens. Despite these differences, mutations across α-, β-, and γ-crystallins converge on common pathogenic mechanisms by perturbing protein stability, intermolecular interactions, and solubility, thereby promoting protein misfolding, aggregation, or aberrant phase behavior. Such alterations disrupt lens protein homeostasis, increase light scattering, and ultimately lead to lens opacification. Cataract-related imaging and genetic data are increasingly being analyzed using emerging computational approaches, among which artificial intelligence (AI) represents a rapidly developing direction that may further support the interpretation of disease phenotypes and molecular variants in future studies. In this review, we synthesize current knowledge on human crystallin variation, pathogenic mechanisms of crystallin gene mutations, and cataract phenotypes, and discuss how AI-assisted approaches may further refine mechanistic interpretation and molecular characterization of cataract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.